Literature DB >> 31308111

Venous thromboembolism and palliative care.

Simon Noble1.   

Abstract

The management of cancer-associated thrombosis (CAT) is largely informed by data from adequately powered randomised control trials. However, their exclusion criteria have invariably rendered the study populations unrepresentative of those seen day-to-day by palliative care practitioners.Recent observational data has given insights into the unique challenges of CAT management within the palliative care setting including the natural history of thrombosis in advanced cancer and end-of-life decision making around anticoagulationDespite developments and some on-going uncertainties, one constant remains; the patient and their experiences. We should, wherever possible, involve them in the decision-making process particularly where the evidence is lacking. By appreciating the values and concerns of our patients, we shall be able to plan care that most meets their needs. © Royal College of Physicians 2019. All rights reserved.

Entities:  

Keywords:  Cancer associated thrombosis; DOACs; hospice; low molecular weight heparin; palliative; venous thromboembolism

Mesh:

Substances:

Year:  2019        PMID: 31308111      PMCID: PMC6752239          DOI: 10.7861/clinmedicine.19-4-315

Source DB:  PubMed          Journal:  Clin Med (Lond)        ISSN: 1470-2118            Impact factor:   2.659


  20 in total

1.  Role of D-dimers in diagnosis of venous thromboembolism.

Authors:  J Kelly; B J Hunt
Journal:  Lancet       Date:  2002-02-09       Impact factor: 79.321

Review 2.  Deep venous thrombosis: recent advances and optimal investigation with US.

Authors:  J D Fraser; D R Anderson
Journal:  Radiology       Date:  1999-04       Impact factor: 11.105

3.  Deep vein thrombosis and pulmonary embolism. An autopsy study with multiple regression analysis of possible risk factors.

Authors:  O Havig
Journal:  Acta Chir Scand Suppl       Date:  1977

4.  Management of challenging cases of patients with cancer-associated thrombosis including recurrent thrombosis and bleeding: guidance from the SSC of the ISTH.

Authors:  M Carrier; A A Khorana; J I Zwicker; S Noble; A Y Y Lee
Journal:  J Thromb Haemost       Date:  2013-09       Impact factor: 5.824

Review 5.  The prevention of hospital-acquired venous thromboembolism in the United Kingdom.

Authors:  Beverley J Hunt
Journal:  Br J Haematol       Date:  2008-11-29       Impact factor: 6.998

6.  Barriers to the diagnosis and treatment of venous thromboembolism in advanced cancer patients: a qualitative study.

Authors:  Laura Sheard; Hayley Prout; Dawn Dowding; Simon Noble; Ian Watt; Anthony Maraveyas; Miriam Johnson
Journal:  Palliat Med       Date:  2012-10-23       Impact factor: 4.762

Review 7.  The challenges of managing cancer related venous thromboembolism in the palliative care setting.

Authors:  S Noble
Journal:  Postgrad Med J       Date:  2007-11       Impact factor: 2.401

Review 8.  International clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer.

Authors:  D Farge; P Debourdeau; M Beckers; C Baglin; R M Bauersachs; B Brenner; D Brilhante; A Falanga; G T Gerotzafias; N Haim; A K Kakkar; A A Khorana; R Lecumberri; M Mandala; M Marty; M Monreal; S A Mousa; S Noble; I Pabinger; P Prandoni; M H Prins; M H Qari; M B Streiff; K Syrigos; H Bounameaux; H R Büller
Journal:  J Thromb Haemost       Date:  2013-01       Impact factor: 5.824

9.  Factors influencing hospice thromboprophylaxis policy: a qualitative study.

Authors:  S I R Noble; A Nelson; I G Finlay
Journal:  Palliat Med       Date:  2008-09-04       Impact factor: 4.762

Review 10.  Epidemiology and pathophysiology of cancer-associated thrombosis.

Authors:  S Noble; J Pasi
Journal:  Br J Cancer       Date:  2010-04-13       Impact factor: 7.640

View more
  4 in total

1.  Nudge nudge, wink wink.

Authors:  Anton Emmanuel
Journal:  Clin Med (Lond)       Date:  2019-07       Impact factor: 2.659

2.  Consensus statement of the Spanish Society of Internal Medicine and the Spanish Society of Medical Oncology on secondary thromboprophylaxis in patients with cancer.

Authors:  T Quintanar; C Font; E Gallardo; R Barba; B Obispo; C Díaz-Pedroche
Journal:  Clin Transl Oncol       Date:  2020-09-03       Impact factor: 3.405

3.  Venous Thromboembolism in Patients with Cancer Receiving Specialist Palliative Care.

Authors:  Silvia Rosa Allende-Pérez; Gabriela Cesarman-Maus; Adriana Peña-Nieves; Amelia Arcos; Patricia Baz-Gutiérrez; Joanna Robles; Thomas W LeBlanc
Journal:  Clin Appl Thromb Hemost       Date:  2022 Jan-Dec       Impact factor: 2.389

Review 4.  Direct Oral Anticoagulants in Cancer Patients. Time for a Change in Paradigm.

Authors:  Marek Z Wojtukiewicz; Piotr Skalij; Piotr Tokajuk; Barbara Politynska; Anna M Wojtukiewicz; Stephanie C Tucker; Kenneth V Honn
Journal:  Cancers (Basel)       Date:  2020-05-02       Impact factor: 6.639

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.